RecruitingNot ApplicableNCT05538338

Platelet Rich Plasma for Insufficient Endometrium

Intrauterine Platelet Rich Plasma (PRP) Infusion for Endometrial Insufficiency: A Prospective, Double-Blind, Placebo-Controlled Randomized Controlled Trial


Sponsor

Reproductive Medicine Associates of New Jersey

Enrollment

62 participants

Start Date

Oct 15, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

To determine the effectiveness of an intrauterine PRP infusion on endometrial thickness and in vitro fertilization (IVF) outcomes in a population of infertile women with a history of unresponsive thin endometrium.


Eligibility

Sex: FEMALEMin Age: 18 YearsMax Age: 45 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Normal saline Intrauterine infusion and Platelet Rich Plasma Intrauterine infusion for people with infertility of uterine origin. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 18 Years to 45 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERPlatelet Rich Plasma Intrauterine infusion

an intrauterine infusion of platelet rich plasma (PRP) will be administered to this group of participants

OTHERNormal saline Intrauterine infusion

an intrauterine infusion of normal saline will be administered to this group of participants


Locations(1)

Reproductive Medicine Associates of New Jersey

Basking Ridge, New Jersey, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05538338


Related Trials